Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib vs imatinib in newly diagnosed chronic phase Ph+ CML
CTR20132967Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bosutinib in chronic myelogenous leukemia (CML), sponsored by Pfizer. Started Apr 2015; status: completed.
02
Drugs
bosutinib
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on CTR20132967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132967.